Kevin M Gersten

Title: Kevin M Gersten: Innovator in Fucosyltransferase Research

Introduction

Kevin M Gersten is a notable inventor based in Fremont, California. He has made significant contributions to the field of biochemistry, particularly in the area of fucosyltransferase research. His work has implications for understanding various biological processes and potential therapeutic applications.

Latest Patents

Kevin M Gersten holds a patent for "Murine α(1,3) Fucosyltransferase FUC-TVII, DNA Encoding the Same, Method for Preparing the Same, Antibodies Recognizing the Same, Immunoassays for Detecting the Same, Plasmids Containing Such DNA, and Cells Containing Such a Plasmid." This patent describes a gene that encodes a murine leukocyte α(1,3) fucosyltransferase capable of synthesizing the sialyl Lewis x determinant, which has been cloned for further research.

Career Highlights

Kevin is affiliated with the University of Michigan, where he continues to advance his research in fucosyltransferases. His work has contributed to a deeper understanding of glycosylation processes and their roles in cell signaling and immune responses.

Collaborations

Throughout his career, Kevin has collaborated with esteemed colleagues such as Shunji Natsuka and John B Lowe. These collaborations have enriched his research and expanded the impact of his findings in the scientific community.

Conclusion

Kevin M Gersten's innovative work in the field of fucosyltransferase research exemplifies the importance of scientific inquiry in understanding complex biological systems. His contributions continue to influence the landscape of biochemistry and molecular biology.